BEIJING N STAR (00588) recorded a net loss of 151 million yuan attributable to equity holders in the first quarter, a decrease of 48.83% compared to the same period last year.
Beijing Beichen Industrial Co., Ltd. (00588) released its first quarter report for 2026, with the company achieving operating income of RMB 1.282 billion (unit in the same below), a year-on-year increase of 7.26%; net loss attributable to the shareholders of the listed company was RMB 151 million, a year-on-year decrease of 48.83%; basic loss per share was RMB 0.04.
BEIJING N STAR (00588) released its first quarter report for 2026, with the company achieving operating revenue of RMB 1.282 billion (all in the same unit), a year-on-year increase of 7.26%; net loss attributable to shareholders of the listed company was RMB 151 million, a year-on-year decrease of 48.83%; basic loss per share was RMB 0.04.
Related Articles
Midea Group Co., Ltd (00300) had a first quarter attributable net profit of 12.675 billion yuan, an increase of 2.03% year-on-year.
MICROPORT NEURO (02172) spent approximately HK$1.0348 million to repurchase 100,000 shares on April 29th.
Hansoh Pharma (03692): B7-H3 targeted antibody-drug conjugate HS-20093 approved as breakthrough therapy for castration-resistant prostate cancer.
Midea Group Co., Ltd (00300) had a first quarter attributable net profit of 12.675 billion yuan, an increase of 2.03% year-on-year.
MICROPORT NEURO (02172) spent approximately HK$1.0348 million to repurchase 100,000 shares on April 29th.
Hansoh Pharma (03692): B7-H3 targeted antibody-drug conjugate HS-20093 approved as breakthrough therapy for castration-resistant prostate cancer.
RECOMMEND
